KMO and cardiac hypertrophy: This study demonstrated that protocatechuic acid treatment alleviates cardiac hypertrophy, fibrosis, oxidative stress, and dysfunction in an isoproterenol‐induced heart failure mouse model by downregulating Kmo (Figure 8G).